相关实验视频
Updated: Jul 22, 2026

05:05
Ultrasound Cyclo Plasty in Eyes with Glaucoma
Published on: January 26, 2018
12.6K
使用原始和修订的帕斯普拉纳探测器进行微脉冲跨细胞循环光凝血的有效性和安全性
Rohan Daniel1, Premanand Chandran1, Mohammed S Uduman2
1Department of Glaucoma, Aravind Eye Hospital, Coimbatore, Tamil Nadu, India.
Indian journal of ophthalmology
|January 7, 2026
概括
微脉冲横循环光凝血 (MP-TSCPC) 有效地降低了青光眼患者的眼内压力 (IOP). 虽然原始和修订的探针都显示出疗效,但治疗方法是有效的.
科学领域:
- 眼科医生 眼科 眼科
- 青光眼治疗方法 青光眼治疗方法
- 手术创新 在外科创新.
背景情况:
- 眼管理需要有效的眼内压力 (IOP) 降低.
- 微脉冲穿细胞循环光凝血 (MP-TSCPC) 是一种微创的玻璃眼外科手术.
- 评估不同的探头设计对于优化MP-TSCPC结果至关重要.
研究的目的:
- 为了比较MP-TSCPC的有效性和安全性,使用原始与修订的帕斯普拉纳探头.
- 评估探头设计对IOP降低和药物使用的影响.
- 为了确定MP-TSCPC在青光眼患者的长期有效性.
主要方法:
- 对接受MP-TSCPC (2020年8月 - 2023年7月) 的青光眼患者的回顾性图表审查.
- 纳入标准:年龄>12岁,至少1年的随访.
- 成功定义为6-21mmHg之间的内血压,降低药物使用和≥20%的内血压降低.
主要成果:
- 一年后,原始 (33.3%) 和修订 (40.9%) 探针之间的IOP减少没有显著差异.
- 这两种探测都导致了统计学上显著的IOP减少 (P < 0.001和P = 0.009).
- 两种探针的平均药物使用量都下降了,这表明改善了对青光眼的控制.
结论:
- MP-TSCPC是使用两种探针类型的安全有效的玻璃眼治疗方法.
- MP-TSCPC的疗效可能无法长期维持.
- 对探头设计的进一步研究可能会增强持续的IOP控制.
更多相关视频
相关概念视频
Extracorporeal Removal of Drugs: Peritoneal Dialysis and Hemodialysis
Patients with end-stage renal disease (ESRD) or those experiencing drug overdose often require extracorporeal methods to eliminate accumulated drugs and metabolites. Hemoperfusion, hemofiltration, and dialysis are the primary techniques to rapidly remove harmful substances without disrupting the patient's fluid and electrolyte balance. For those with compromised renal function, dosage adjustments of concurrent medications may be necessary during extracorporeal drug removal.Dialysis is a process...
Ophthalmic Drug Delivery Systems
Ophthalmic drug delivery faces major limitations due to poor absorption across the corneal membrane. This process is primarily driven by diffusion and is influenced by two main factors: the physicochemical properties of the drug and tear drainage. Most ophthalmic drugs, such as pilocarpine, epinephrine, atropine, and local anesthetics, are weak bases. They are typically formulated at an acidic pH to enhance chemical stability. However, this leads to high ionization, reducing their ability to...
Peritoneal Dialysis I: Introduction and Procedure
Peritoneal dialysis (PD) is a procedure that facilitates the exchange of solutes, waste products, electrolytes, and excess fluid between the blood in the peritoneal capillaries and a dialysis solution introduced into the peritoneal cavity.Principles of Peritoneal Dialysis (PD)Diffusion: Waste products such as urea and electrolytes move from high concentrations in the blood to low concentrations in the dialysate across the peritoneal membrane. This mechanism is driven by the concentration...
Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications
Peritoneal dialysis (PD) is a medical process that removes waste products and excess fluid from the body using the peritoneal membrane as a natural filter.Peritoneal Dialysis MethodsSeveral methods can be used for peritoneal dialysis, including Acute Intermittent Peritoneal Dialysis, Continuous Ambulatory Peritoneal Dialysis, and Automated Peritoneal Dialysis, also known as Continuous Cyclic Peritoneal Dialysis.Acute Intermittent Peritoneal Dialysis (AIPD) is used for patients with uremic...
Hemodialysis II: Procedure and Complications
DialyzersA hemodialysis (HD) dialyzer is a plastic cartridge containing thousands of parallel hollow fibers, which serve as semipermeable membranes. These fibers are typically made from cellulose-based or other synthetic materials. During HD, blood is pumped into the top of the cartridge and distributed among these fibers. Simultaneously, dialysis fluid, known as dialysate, is introduced into the bottom of the cartridge, bathing the outside of the fibers. Across the semipermeable membrane,...

